Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05954871 |
|---|---|
| Brief Title: | Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Either Osimertinib in Participants With Unresectable, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer, or With Cetuximab in Participants With Metastatic Colorectal Cancer |
| First Submitted : | July 12, 2023 |
| First Submitted that Met QC Criteria : | July 12, 2023 |
| First Posted : | July 20, 2023 |
| Last Update Submitted that Met QC Criteria : | April 30, 2024 |
| Last Update Posted : | May 1, 2024 |